Senomyx (NASDAQ:SNMX) was upgraded by analysts at ValuEngine from a “strong sell” rating to a “sell” rating in a research note issued to investors on Friday.
Separately, Zacks Investment Research cut Senomyx from a “buy” rating to a “hold” rating in a research report on Wednesday, November 29th.
Shares of Senomyx (SNMX) opened at $1.19 on Friday. Senomyx has a 1 year low of $0.56 and a 1 year high of $1.71. The firm has a market capitalization of $56.39, a P/E ratio of -4.58 and a beta of 1.39.
A hedge fund recently raised its stake in Senomyx stock. Cowen Prime Services LLC grew its holdings in Senomyx Inc. (NASDAQ:SNMX) by 121.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 737,441 shares of the specialty chemicals company’s stock after buying an additional 404,290 shares during the quarter. Cowen Prime Services LLC owned about 1.54% of Senomyx worth $959,000 at the end of the most recent quarter. 26.72% of the stock is owned by institutional investors and hedge funds.
WARNING: This article was originally reported by Sports Perspectives and is owned by of Sports Perspectives. If you are accessing this article on another publication, it was illegally copied and republished in violation of US & international copyright & trademark law. The original version of this article can be viewed at https://sportsperspectives.com/2018/02/02/senomyx-snmx-lifted-to-sell-at-valuengine.html.
Senomyx Company Profile
Senomyx, Inc is focused on using taste receptor technologies to discover, develop and commercialize flavor ingredients for the packaged food, beverage and ingredient supply industries. The Company operates through development and commercialization of flavor ingredients segment. It is engaged in the discovery, development and/or commercialization of flavor ingredients through over five programs.
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Senomyx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senomyx and related companies with MarketBeat.com's FREE daily email newsletter.